Biocytogen Pharms (Beijing) (2315)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 27 Oct 2026
Key indicators
| Last close | HKD 40.04 |
|---|---|
| 52-week range | 23.02 – 80.65 |
| Return, 1 month / 3 months | −41.4% / −26.0% |
| Return, 1 year / 3 years | +57.3% / +239.3% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 84.8% |
| Worst drawdown (1 year) | -49.8% |
| Average daily value traded | 125.96M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Biocytogen Pharms (Beijing) (2315) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 40.04 on 27 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 1,246 of 2,619 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 57.3% and over the last three months it fell 26.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -24.2% | ||
| From 52-week high | -49.8% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -26.0% | ||
| 6-month return | -32.0% | ||
| 12-month return, skipping the last month | 168.3% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 84.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.8% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 125.96M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −15.3% |
|---|---|
| 1 month | −41.4% |
| 3 months | −26.0% |
| 6 months | −32.0% |
| 1 year | +57.3% |
| 3 years | +239.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 60.35 / 52.82 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.03 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.